[Federal Register Volume 62, Number 124 (Friday, June 27, 1997)]
[Notices]
[Page 34761]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-16785]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Cancer Institute Special Emphasis Panel (SEP) meeting:

    Name of SEP: Evaluation of Chempreventive Agents by In Vitro 
Techniques.
    Date: July 28-29, 1997.
    Time: 9:00 a.m. to 5:00 p.m.
    Place: DoubleTree Hotel--Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Latita Palekar, Ph.D., Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 601D, 6130 Executive Boulevard, MSC 7410, Bethesda, MD 
20892-7410, Telephone: 301/496-7575.
    Purpose/Agenda To evaluate and review response to Request for 
Proposals.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. 
Applications and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog Of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: June 20, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-16785 Filed 6-26-97; 8:45 am]
BILLING CODE 4140-01-M